Antiemetic control of palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen containing either irinotecan or oxaliplatin.
M. A. Blazer
Consultant or Advisory Role - Eisai
J. Reardon
No relevant relationships to disclose
D. Efries
No relevant relationships to disclose
Y. T. Smith
No relevant relationships to disclose
L. M. Weatherby
No relevant relationships to disclose
K. Juergens
No relevant relationships to disclose
T. Criswell
No relevant relationships to disclose
J. S. Rose
No relevant relationships to disclose
G. S. Phillips
No relevant relationships to disclose
N. Griffith
Consultant or Advisory Role - Eisai
T. S. Bekaii-Saab
No relevant relationships to disclose